Isodose patterns in patients with inadequate prostate brachytherapy coverage

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 5, 2003, Pages 1480-1487

  Reed, Daniel R ^a,b   Wallner, Kent E ^a,b,c   Merrick, Gregory ^d   Butler, Wayne ^d   Han, Ben H ^a   Sutlief, Steve G ^a,b   Cho, Paul S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d WHEELING HOSPITAL   (United States)

Author keywords

Brachytherapy; Dosimetry; Prostate

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DOSIMETRY; PATIENT MONITORING; RADIOTHERAPY; REAL TIME SYSTEMS;

REAL TIME DOSIMETRY SYSTEM;

TUMORS;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL PATHWAY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; HUMAN; IMAGE ANALYSIS; IMPLANT; MAJOR CLINICAL STUDY; MALE; PEROPERATIVE ECHOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; RADIATION DOSE DISTRIBUTION; STATISTICAL ANALYSIS; TREATMENT PLANNING;

EID: 0038503568     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00527-3     Document Type: Article

References (21)

1. Stock R.G., Stone N.N., Lo Y.C., et al. Postimplant dosimetry for 125-I prostate implants Definitions and factors affecting outcome . Int J Radiat Oncol Biol Phys. 48:2000;899-906.
2. Potters L., Cao Y., Calugaru E., et al. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 50:2001;605-614.
3. Wallner K, Merrick G, True L, et al. I-125 versus Pd-103 for low risk prostate cancer: Preliminary biochemical outcomes from a prospective randomized mulitcenter trial. Submitted.
4. Waterman F.M., Yue N., Corn B.W., et al. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry An analysis based on serial CT acquisition . Int J Radiat Oncol Biol Phys. 41:1998;1069-1077.
5. Chen Z., Yue N., Wang X., et al. Dosimetric effects of edema in permanent prostate seed implants A rigorous solution . Int J Radiat Oncol Biol Phys. 47:2000;1405-1419.
6. Prestidge B.R., Bice W.S., Kiefer E.J., et al. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy. Int J Radiat Oncol Biol Phys. 40:1998;1111-1115.
7. Nag S., Bice W., DeWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys. 46:2000;221-230.
8. Bice W.S., Prestidge B.R., Grimm P.D., et al. Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys. 41:1998;921-927.
9. Bice W.S., Prestidge B.R., Sarosody M.F. Sector analysis of prostate implants. Med Phys. 28:2001;2561-2567.
10. Sidhu S., Morris W.J., Spadinger I., et al. Prostate brachytherapy postimplant dosimetry A comparison of prostate quadrants . Int J Radiat Oncol Biol Phys. 52:2002;544-552.
11. Mueller A., Wallner K., Merrick G., et al. Modification of prostate implants based on post-implant treatment margin assessment. Med Phys. 29:2003;2782-2787.
12. Haworth A., Ebert M., Joseph D., et al. Registration of prostate volume with radiographically identified Iodine-125 seeds for permanent implant evaluation. J Brachy Intl. 16:2000;157-167.
13. Gong L., Cho P., Han B., et al. Registration of prostate brachytherapy seeds with prostate anatomy for postimplant dosimetry. Int J Radiat Oncol Biol Phys. 54:2002;1322-1330.
14. Wallner K., Merrick G., True L., et al. I-125 versus Pd-103 for low risk prostate cancer Morbidity outcomes from a prospective randomized multicenter trial . Ca J Sci American. 8:2002;67-73.
15. Merrick G.S., Butler W.M. Modified uniform seed loading for prostate brachytherapy Rationale, design, and evaluation . Techniques in Urology. 6:2000;78-84.
16. Mueller A, Wallner K, Corriveau J, et al. A reappraisal of local anesthesia for prostate brachytherapy. Radiother Oncol. In press.
17. Badiozamani K.R., Wallner K.E., Cavanagh W., et al. Comparability of CT-based and TRUS-based prostate volumes. Int J Radiat Oncol Biol Phys. 43:1999;375-378.
18. Speight J.L., Shinohara K., Pickett B., et al. Prostate volume change after radioactive seed implantation Possible benefit of improved dose volume histogram with perioperative steroid . Int J Radiat Oncol Biol Phys. 48:2000;1461-1467.
19. Dicker A.P., Lin C.-C., Leeper D.B., et al. Isotope selection for permanent prostate implants? An evaluation of 103-Pd versus 125- based on radiobiological effectiveness and dosimetry . Semin Urol Oncol. 18:2000;152-159.
20. Smith S, Wallner K, Merrick G, et al, Interpretation of pre- versus post-implant TRUS images. Med Phys 2003;30:920-924.
21. Han B, Wallner K, Merrick G, et al. Prostate brachytherapy seed identification on post-implant TRUS images. Med Phys 2003;30:898-900.